|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.95 USD | -4.82% |
|
+1.54% | -17.71% |
| Apr. 15 | Sector Update: Health Care Stocks Gain Monday Afternoon | MT |
| Apr. 15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |  |
Jan 9 (Reuters) - Novavax Inc said on Monday that Chief Executive Officer Stanley Erck would retire and be succeeded by industry veteran John Jacobs.
Jacobs joins Novavax from Harmony Biosciences, where he served as chief executive officer since June 2018. (Reporting by Raghav Mahobe in Bengaluru; Editing by Saumyadeb Chakrabarty)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 28.93 USD | -1.03% | -0.34% | 1.64B | ||
| 3.95 USD | -4.82% | +1.54% | 553M | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -17.71% | 553M | |
| +1.12% | 42.59B | |
| +6.77% | 40.65B | |
| +47.70% | 40.57B | |
| -11.96% | 26.77B | |
| +6.01% | 24.81B | |
| -24.92% | 18.17B | |
| -3.63% | 11.7B | |
| +27.16% | 12.05B | |
| +7.30% | 11.1B |
NOVAVAX, INC. 
